Peel Hunt Limited Reiterates Spirax Group plc

Peel Hunt Limited reiterated a "Buy" recommendation for Spirax Group plc (OTCPK:SPXSY) on November 13, 2025, despite the average analyst price target of $50.42/share suggesting a 10.96% downside from its latest closing price of $56.63. The company projects robust fundamentals, including an 18.10% increase in annual revenue to $1,961MM and a non-GAAP EPS of $4.48. Concurrently, institutional interest in SPXSY is growing, with total shares owned by institutions increasing by 34.98% to 333K shares and the average portfolio weight dedicated to the stock rising by 24.65% over the last quarter.

Analysis

Peel Hunt Limited reiterated a "Buy" recommendation for Spirax Group plc (OTCPK:SPXSY) on November 13, 2025, despite the average one-year price target of $50.42/share suggesting a 10.96% downside from its $56.63 closing price. This recommendation is underpinned by strong projected fundamentals, including an 18.10% increase in annual revenue to $1,961MM and a non-GAAP EPS of $4.48. The analyst's positive stance, despite the lower price target, implies a focus on long-term value or qualitative strengths.

Institutional interest in SPXSY is notably increasing, with total shares owned by institutions rising by 34.98% to 333K shares over the last three months. The average portfolio weight dedicated to SPXSY across reporting funds also grew by 24.65% to 0.55%. This significant increase in both share count and allocation, while the number of funds remained stable at eight, indicates strengthening conviction among institutional investors.

Individual institutional filings show major holders like NMVLX and Jnl Series Trust significantly increased their share counts by 34.15% and 36.16% respectively, alongside substantial increases in portfolio allocation. While NCVLX reduced its share count by 12.75%, it still increased its portfolio allocation by 2.12%, suggesting a relative re-weighting. This predominantly positive institutional activity signals a nuanced but generally bullish sentiment.

Key Decisions for Investors

• Investors should reconcile the "Buy" recommendation with the average analyst price target indicating a 10.96% downside from the current share price.
• Focus on the strong projected fundamentals, including 18.10% annual revenue growth and $4.48 non-GAAP EPS, as potential long-term value drivers.
• Monitor the continued institutional accumulation, evidenced by a 34.98% increase in total shares owned, as a sign of strengthening conviction.
• Consider the implications of the current share price exceeding the average target, assessing the risk/reward profile for new positions or re-evaluating existing ones.